DRUVIQLO
Live / Registered — Registered (as of 07 Mar 2023)
What this means for you
Registered since 07 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79353041
- Registration number
- 6994003
- Mark type
- Stylized text
- Filed
- 23 Aug 2022
- Published for opposition
- 20 Dec 2022
- Registered
- 07 Mar 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Owner
- Novartis AG, CH
- Novartis AG, CH
- Novartis AG, CH
Prosecution history
- 09 May 2023 — NOTIFICATION PROCESSED BY IB
- 20 Apr 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 20 Apr 2023 — FINAL DISPOSITION PROCESSED
- 06 Apr 2023 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 07 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 22 Dec 2022 — NOTIFICATION PROCESSED BY IB
- 20 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Dec 2022 — PUBLISHED FOR OPPOSITION
- 30 Nov 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 30 Nov 2022 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 30 Nov 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Nov 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Nov 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Nov 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED